Peritoneal disease in breast cancer: A specific entity with an extremely poor prognosis

European Journal of Cancer

Volumn 45, Issue 12, 2009, Pages 2146-2149

  Tuthill, Mark ^a   Pell, Robert ^a   Guiliani, Rosa ^a   Lim, Adrian ^a   Gudi, Mihir ^b   Contractor, Kaiyumars B ^b   Lewis, Jacqueline S ^a   Coombes, R Charles ^a   Stebbing, Justin ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Metastasis; Peritoneal; Prognosis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; TRASTUZUMAB;

ADULT; ARTICLE; ASCITES; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MIDDLE AGED; NEOPLASM STAGING; PERITONEAL NEOPLASMS; PREVALENCE; PROGNOSIS; YOUNG ADULT;

EID: 67651091572     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.04.027     Document Type: Article

References (14)

1. Saunders Y., Stebbing J., Broadley K., and Johnston S.R. Recurrent locally advanced breast cancer: the treatment of chest wall disease with further chemotherapy. Clin Oncol (R Coll Radiol) 13 (2001) 195-199
2. Stebbing J., Crane J., and Gaya A. Breast cancer (metastatic). Clin Evid (2006) 2331-2359
3. Lee B., Franklin I., Lewis J.S., Coombes R.C., Leonard R., Gishen P., and Stebbing J. The efficacy of percutaneous vertebroplasty for vertebral metastases associated with solid malignancies. Eur J Cancer (2009)
4. Horlock C., Stott B., Dyson P.J., Morishita M., Coombes R.C., Savage P., and Stebbing J. The effects of trastuzumab on the CD4+CD25+FoxP3+ and CD4+IL17A+ T-cell axis in patients with breast cancer. Br J Cancer (2009)
5. Borst M.J., and Ingold J.A. Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. Surgery 114 (1993) 637-641 discussion 641-642
6. Abu-Rustum N.R., Aghajanian C.A., Venkatraman E.S., Feroz F., and Barakat R.R. Metastatic breast carcinoma to the abdomen and pelvis. Gynecol Oncol 66 (1997) 41-44
7. Fondrinier E., Guerin O., and Lorimier G. A comparative study of metastatic patterns of ductal and lobular carcinoma of the breast from two matched series (376 patients). Bull Cancer 84 (1997) 1101-1107
8. Sheen-Chen S.M., Liu Y.W., Sun C.K., Lin S.E., Eng H.L., Huang W.T., et al. Abdominal carcinomatosis attributed to metastatic breast carcinoma. Dig Dis Sci 53 (2008) 3043-3045
9. Lee B., Lim A., Lalvani A., et al. The clinical significance of radiologically detected silent pulmonary nodules in early breast cancer. Ann Oncol 19 (2008) 2001-2006
10. Bookman M.A., Greer B.E., and Ozols R.F. Optimal therapy of advanced ovarian cancer: carboplatin and paclitaxel vs. cisplatin and paclitaxel (GOG 158) and an update on GOG0 182-ICON5. Int J Gynecol Cancer 13 (2003) 735-740
11. Winchester D.J., Chang H.R., Graves T.A., Menck H.R., Bland K.I., and Winchester D.P. A comparative analysis of lobular and ductal carcinoma of the breast: presentation, treatment, and outcomes. J Am Coll Surg 186 (1998) 416-422
12. Mazhar D., Stebbing J., and Bower M. Non-Hodgkin's lymphoma and the CNS: prophylaxis and therapy in immunocompetent and HIV-positive individuals. Expert Rev Anticancer Ther 6 (2006) 335-341
13. Zou H.Y., Li Q., Lee J.H., et al. An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms. Cancer Res 67 (2007) 4408-4417
14. D'Angelo N.D., Bellon S.F., Booker S.K., et al. Design, synthesis, and biological evaluation of potent c-Met inhibitors. J Med Chem 51 (2008) 5766-5779